S&P 500
3,319.47-37.54(-1.12%)Nasdaq
10,793.28-117.02(-1.07%)Russell 2000
1,536.78-5.82(-0.38%)
Pulse Biosciences, Inc. (PLSE)
- Business Wire
Pulse Biosciences Grants Equity Incentive Awards To New Employees
Pulse Biosciences, Inc. (Nasdaq: PLSE) ("Pulse Biosciences" or the "Company") a novel bioelectric medicine company progressing Nano-Pulse Stimulation™ (NPS™) technology, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 77,250 shares of Pulse Biosciences common stock to recently hired non-executive employees under the Pulse Biosciences 2017 Inducement Equity Incentive Plan on September 15, 2020.
- Business Wire
Pulse Biosciences to Participate in the H.C. Wainwright Global Investment Conference
Pulse Biosciences, Inc. (Nasdaq: PLSE) a novel bioelectric medicine company progressing Nano-Pulse Stimulationâ„¢ (NPSâ„¢) technology, today announced plans to virtually participate in the upcoming H.C. Wainwright Global Investment Conference.
- Motley Fool
Pulse Biosciences, Inc. (PLSE) Q2 2020 Earnings Call Transcript
With that, I would now like to turn the call over to President and Chief Executive Officer, Darrin Uecker. This afternoon, we look forward to providing you with an update on all the recent progress made by our team at Pulse Biosciences.
